Procept Biorobotics Corp
PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. It also provides HYDROS Rob… Read more
Procept Biorobotics Corp (PRCT) - Total Liabilities
Latest total liabilities as of September 2025: $131.26 Million USD
Based on the latest financial reports, Procept Biorobotics Corp (PRCT) has total liabilities worth $131.26 Million USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Procept Biorobotics Corp - Total Liabilities Trend (2019–2024)
This chart illustrates how Procept Biorobotics Corp's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Procept Biorobotics Corp Competitors by Total Liabilities
The table below lists competitors of Procept Biorobotics Corp ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Atlantica Sustainable Infrastructure PLC
NASDAQ:AY
|
USA | $7.15 Billion |
|
Apollo Tyres Limited
NSE:APOLLOTYRE
|
India | ₹134.76 Billion |
|
Magyar Telekom Távközlési Nyilvánosan Müködö Részvénytársaság
F:MGYB
|
Germany | €631.60 Billion |
|
Inspire Medical Systems Inc
NYSE:INSP
|
USA | $137.33 Million |
|
Polestar Automotive Holding UK PLC Class C-1 ADS (ADW)
NASDAQ:PSNYW
|
USA | $7.91 Billion |
|
Shaanxi Energy Investment Co Ltd. A
SHE:001286
|
China | CN¥37.65 Billion |
|
Milbon Co. Ltd
PINK:MIOFF
|
USA | $8.48 Billion |
|
Elvalhalcor Hellenic Copper and Aluminium Industry S.A
AT:ELHA
|
Greece | €1.42 Billion |
Liability Composition Analysis (2019–2024)
This chart breaks down Procept Biorobotics Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 8.43 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.35 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.26 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Procept Biorobotics Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Procept Biorobotics Corp (2019–2024)
The table below shows the annual total liabilities of Procept Biorobotics Corp from 2019 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $131.80 Million | +6.32% |
| 2023-12-31 | $123.97 Million | +10.43% |
| 2022-12-31 | $112.26 Million | +60.52% |
| 2021-12-31 | $69.93 Million | +7.57% |
| 2020-12-31 | $65.01 Million | +98.42% |
| 2019-12-31 | $32.76 Million | -- |